Year |
Citation |
Score |
2012 |
Antal Z, Baker JC, Smith C, Jarchum I, Babad J, Mukherjee G, Yang Y, Sidney J, Sette A, Santamaria P, DiLorenzo TP. Beyond HLA-A*0201: new HLA-transgenic nonobese diabetic mouse models of type 1 diabetes identify the insulin C-peptide as a rich source of CD8+ T cell epitopes. Journal of Immunology (Baltimore, Md. : 1950). 188: 5766-75. PMID 22539795 DOI: 10.4049/Jimmunol.1102930 |
0.629 |
|
2010 |
Brims DR, Qian J, Jarchum I, Mikesh L, Palmieri E, Ramagopal UA, Malashkevich VN, Chaparro RJ, Lund T, Hattori M, Shabanowitz J, Hunt DF, Nathenson SG, Almo SC, Dilorenzo TP. Predominant occupation of the class I MHC molecule H-2Kwm7 with a single self-peptide suggests a mechanism for its diabetes-protective effect. International Immunology. 22: 191-203. PMID 20093428 DOI: 10.1093/Intimm/Dxp127 |
0.763 |
|
2010 |
Jarchum I, DiLorenzo TP. Ins2 deficiency augments spontaneous HLA-A*0201-restricted T cell responses to insulin. Journal of Immunology (Baltimore, Md. : 1950). 184: 658-65. PMID 19966211 DOI: 10.4049/Jimmunol.0903414 |
0.769 |
|
2009 |
Gao HX, Campbell SR, Burkly LC, Jakubowski A, Jarchum I, Banas B, Saleem MA, Mathieson PW, Berman JW, Michaelson JS, Putterman C. TNF-like weak inducer of apoptosis (TWEAK) induces inflammatory and proliferative effects in human kidney cells. Cytokine. 46: 24-35. PMID 19233685 DOI: 10.1016/J.Cyto.2008.12.001 |
0.341 |
|
2008 |
Antal Z, Jarchum I, DiLorenzo TP. HLA class I supertypes in type 1 diabetic children in an urban children's hospital. Annals of the New York Academy of Sciences. 1150: 86-9. PMID 19120273 DOI: 10.1196/Annals.1447.005 |
0.732 |
|
2008 |
Jarchum I, Takaki T, DiLorenzo TP. Efficient culture of CD8(+) T cells from the islets of NOD mice and their use for the study of autoreactive specificities. Journal of Immunological Methods. 339: 66-73. PMID 18782577 DOI: 10.1016/J.Jim.2008.08.007 |
0.742 |
|
2008 |
Mukhopadhaya A, Hanafusa T, Jarchum I, Chen YG, Iwai Y, Serreze DV, Steinman RM, Tarbell KV, DiLorenzo TP. Selective delivery of beta cell antigen to dendritic cells in vivo leads to deletion and tolerance of autoreactive CD8+ T cells in NOD mice. Proceedings of the National Academy of Sciences of the United States of America. 105: 6374-9. PMID 18430797 DOI: 10.1073/Pnas.0802644105 |
0.763 |
|
2008 |
Jarchum I, Nichol L, Trucco M, Santamaria P, DiLorenzo TP. Identification of novel IGRP epitopes targeted in type 1 diabetes patients. Clinical Immunology (Orlando, Fla.). 127: 359-65. PMID 18358785 DOI: 10.1016/J.Clim.2008.01.015 |
0.772 |
|
2007 |
Jarchum I, Baker JC, Yamada T, Takaki T, Marron MP, Serreze DV, DiLorenzo TP. In vivo cytotoxicity of insulin-specific CD8+ T-cells in HLA-A*0201 transgenic NOD mice. Diabetes. 56: 2551-60. PMID 17620420 DOI: 10.2337/Db07-0332 |
0.801 |
|
Low-probability matches (unlikely to be authored by this person) |
2016 |
Jarchum I. Tracing cell lineage with 5hmC Nature Methods. 13: 710-711. DOI: 10.1038/nmeth.3986 |
0.277 |
|
2011 |
Jarchum I, Liu M, Lipuma L, Pamer EG. Toll-like receptor 5 stimulation protects mice from acute Clostridium difficile colitis. Infection and Immunity. 79: 1498-503. PMID 21245274 DOI: 10.1128/IAI.01196-10 |
0.181 |
|
2012 |
Jarchum I, Liu M, Shi C, Equinda M, Pamer EG. Critical role for MyD88-mediated neutrophil recruitment during Clostridium difficile colitis. Infection and Immunity. 80: 2989-96. PMID 22689818 DOI: 10.1128/IAI.00448-12 |
0.144 |
|
2012 |
Buffie CG, Jarchum I, Equinda M, Lipuma L, Gobourne A, Viale A, Ubeda C, Xavier J, Pamer EG. Profound alterations of intestinal microbiota following a single dose of clindamycin results in sustained susceptibility to Clostridium difficile-induced colitis. Infection and Immunity. 80: 62-73. PMID 22006564 DOI: 10.1128/IAI.05496-11 |
0.136 |
|
2016 |
Jarchum I. To humans, and beyond! Nature Immunology. 17: S16-S16. DOI: 10.1038/NI.3611 |
0.117 |
|
2011 |
Jarchum I, Pamer EG. Regulation of innate and adaptive immunity by the commensal microbiota. Current Opinion in Immunology. 23: 353-60. PMID 21466955 DOI: 10.1016/j.coi.2011.03.001 |
0.106 |
|
2014 |
Jarchum I. Cell biology: Prostate cancer in 3D. Nature Methods. 11: 1096. PMID 25551127 |
0.093 |
|
2014 |
Lemieux MG, Janzen D, Hwang R, Roldan J, Jarchum I, Knecht DA. Visualization of the actin cytoskeleton: different F-actin-binding probes tell different stories. Cytoskeleton (Hoboken, N.J.). 71: 157-69. PMID 24347465 DOI: 10.1002/Cm.21160 |
0.067 |
|
2018 |
Jarchum I. Reportage from the gut. Nature Biotechnology. 36: 596. PMID 29979650 DOI: 10.1038/nbt.4177 |
0.046 |
|
2016 |
Jarchum I. Proteome quantification compared Nature Methods. 13: 972-972. DOI: 10.1038/nmeth.4096 |
0.043 |
|
2019 |
Jarchum I. Focus on neurotechnologies. Nature Biotechnology. 37: 965. PMID 31485054 DOI: 10.1038/s41587-019-0261-5 |
0.035 |
|
2017 |
Jarchum I. Extending pluripotency with a cocktail Nature Methods. 14: 554-554. DOI: 10.1038/NMETH.4320 |
0.031 |
|
2017 |
Jarchum I. Photosynthesis gets a boost. Nature Biotechnology. 35: 30. PMID 28072773 DOI: 10.1038/nbt.3764 |
0.029 |
|
2018 |
Jarchum I. Putting a number on neoepitope quality. Nature Biotechnology. 36: 151. PMID 29406493 DOI: 10.1038/nbt.4074 |
0.026 |
|
2015 |
Jarchum I. Microbiology: keeping track of gut bacteria. Nature Methods. 12: 908. PMID 26688886 |
0.024 |
|
2018 |
Jarchum I. Getting warmer with liver transplants. Nature Biotechnology. 36: 504. PMID 29874215 DOI: 10.1038/nbt.4158 |
0.024 |
|
2016 |
Jarchum I. RNase footprints re-examined Nature Methods. 13: 397-397. DOI: 10.1038/nmeth.3858 |
0.021 |
|
2014 |
Jarchum I. What's in a stomach? Nature Biotechnology. 32: 1201. PMID 25489838 DOI: 10.1038/nbt.3092 |
0.014 |
|
2017 |
Jarchum I. On-demand rabies Nature Methods. 14: 836-836. DOI: 10.1038/NMETH.4420 |
0.011 |
|
2014 |
Jarchum I. It's porin' CNTs. Nature Methods. 11: 1194. PMID 25584380 DOI: 10.1038/NMETH.3199 |
0.011 |
|
2017 |
Jarchum I. Turning silver dust into electronics. Nature Biotechnology. 35: 723. PMID 28787404 DOI: 10.1038/nbt.3939 |
0.01 |
|
2019 |
Jarchum I. The ethics of neurotechnology. Nature Biotechnology. 37: 993-996. PMID 31485052 DOI: 10.1038/s41587-019-0239-3 |
0.01 |
|
2019 |
DeFrancesco L, Jarchum I. Focus on wearable sensors. Nature Biotechnology. 37: 329. PMID 30940952 DOI: 10.1038/s41587-019-0110-6 |
0.01 |
|
2019 |
Jarchum I. To the stomach and beyond. Nature Biotechnology. 37: 381. PMID 30940941 DOI: 10.1038/s41587-019-0089-z |
0.01 |
|
2019 |
Jarchum I. Double the fun. Nature Methods. 16: 283. PMID 30923377 DOI: 10.1038/s41592-019-0377-z |
0.01 |
|
2018 |
Jarchum I. All the skin that's fit to print. Nature Biotechnology. 36: 410. PMID 29734315 DOI: 10.1038/nbt.4129 |
0.01 |
|
2018 |
Jarchum I. All MiNDS on the brain. Nature Biotechnology. 36: 238. PMID 29509742 DOI: 10.1038/nbt.4094 |
0.01 |
|
2018 |
Jarchum I. Transcriptomics in the NICHE Nature Methods. 15: 165-165. DOI: 10.1038/NMETH.4625 |
0.01 |
|
2017 |
Jarchum I. Stretching sensors by confinement. Nature Biotechnology. 35: 127. PMID 28178248 DOI: 10.1038/nbt.3789 |
0.01 |
|
2017 |
Jarchum I. It takes two to make an embryo Nature Methods. 14: 466-466. DOI: 10.1038/nmeth.4280 |
0.01 |
|
2016 |
Jarchum I. Hacking rules for E. coli. Nature Biotechnology. 34: 1249. PMID 27926721 DOI: 10.1038/nbt.3744 |
0.01 |
|
2016 |
Jarchum I. Alighting on soft robot rays. Nature Biotechnology. 34: 932. PMID 27606460 DOI: 10.1038/nbt.3672 |
0.01 |
|
2016 |
Jarchum I. Getting rid of PERVs. Nature Biotechnology. 34: 46. PMID 26744982 DOI: 10.1038/nbt.3448 |
0.01 |
|
2015 |
Jarchum I. A flexible mesh to record the brain. Nature Biotechnology. 33: 830. PMID 26252143 DOI: 10.1038/nbt.3316 |
0.01 |
|
2015 |
Jarchum I, Jones S. DREAMing of benchmarks. Nature Biotechnology. 33: 49-50. PMID 25574639 DOI: 10.1038/nbt.3115 |
0.01 |
|
2015 |
Jarchum I. Discovering the power of mass-to-charge Nature Methods. 12: 5-5. DOI: 10.1038/NMETH.3517 |
0.01 |
|
2014 |
Jarchum I. A one-two punch knocks out biofilms. Nature Biotechnology. 32: 142. PMID 24509763 DOI: 10.1038/nbt.2813 |
0.01 |
|
2014 |
Jarchum I. Proteome labels à la carte Nature Methods. 11: 614-614. DOI: 10.1038/NMETH.2991 |
0.01 |
|
Hide low-probability matches. |